ADVERTISEMENT

 
FAN logo

Share

    


In This Section

Sign Up For FAN Updates

Home / Learn / Financial Advocacy

Financial Advocacy

The Association of Cancer Care Centers (ACCC) is committed to building the confidence of oncology financial advocates, connecting them with much-needed solutions to improve the patient experience. Through the Financial Advocacy Network’s tools and resources, ACCC empowers cancer programs and practices to proactively integrate financial health into the oncology care continuum and help patients gain access to high-quality care for a better quality of life.

For more information on this project, please contact the ACCC Provider Education department.

 

Featured Programs

Financial Advocacy Guidelines

These guidelines were created using a collaborative, consensus-based process to promote and guide the implementation of critical financial advocacy services in cancer programs and practices across the nation.

Financial Advocacy Boot Camp

Whether you are an experienced financial advocate or new to the field, the ACCC Financial Advocacy Boot Camp prepares you to help your patients and your program address the growing issue of financial toxicity.

Financial Advocacy Playbook

The ACCC Financial Advocacy Network brought together experts in financial advocacy to create this Playbook—a comprehensive tool to support onboarding and continuous learning for staff who deliver financial advocacy services.

Prior Authorization Clinic

ACCC is developing an educational program that will foster discussions on how to ease provider burden and ensure the best quality care for the patient when dealing with the utilization management technique known as prior authorization.

Financial Advocacy: Foundation of Biomarker Testing Courses

Learn the fundamentals of biomarker and diagnostic testing as it relates to financial navigation. Gain confidence in your ability to guide patients through the complex insurance process, practice clear communication strategies, and access helpful financial resources.

Financial Advocacy Toolkit

ACCC, its members, and partners have collected new and updated resources to help you develop, implement, and continue to deliver effective financial advocacy services in your cancer program or practice.

Patient Assistance & Reimbursement Guide

Access the most up-to-date anti-cancer medication assistance and reimbursement programs that are available to help alleviate the financial burden of cancer treatment. Search for applicable Oncology-Related Products and Companies and apply optional Coverage and Assistance Type filters to streamline your results.

FAN Community (ACCC Members Only)

The Financial Advocacy Network Community is a private forum for ACCC members to ask questions, share resources and experiences, and offer support for delivering financial advocacy services to your patients. You will need to login to your ACCC member account in order to access this benefit.

 

On-Demand Webinars

  • In this final webinar, hear from our experts Jordan Karwedsky, Financial Counselor, Green Bay Oncology, Wendi Waugh, BS, RT(R)(T), CMD, CRT, Administrative Director of SOMC Cancer Services & Ambulatory Infusion, Southern Ohio Medical Center, and Dr. Michael R. Gieske, Director of Lung Cancer Screening. Join us as we discuss prior authorization challenges in biomarker testing, importance of providing access to biomarker testing for underserved populations, how biomarkers are shaping the future of medicine, as well as what can be done at the policy level to allow for more access.

  • In the fifth webinar, we will hear from Angie Santiago, CRCS, Manager of Oncology Financial Advocacy, Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System, and Chair of ACCC’s Financial Advocacy Network, and Sarah Shaw, Oncology Program Manager at St. Luke’s Cancer Institute in Boise, ID. Join us as we discuss importance of medical necessity in oncology and how clear denial data can help maximize reimbursement.

  • In the fourth webinar, we will hear from Gretchen Van Dyck, Financial Counselor from St. Vincent Hospital Regional Cancer Center and Rachelle Gill, Program/Department Coordinator II for Proton Therapy Appeals at Fred Hutchinson Cancer Center. Join us as we discuss radiation authorization submissions before treatment and strategies on how to work radiation authorization denials and appeals after treatment.

 

Cancer Buzz Podcasts

From Oncology Issues

 

From the ACCCBuzz Blog

2020 ACCC Innovator Awards: Hospital Event Platform Better Monitors Patient Care


July 30, 2020
tennessee-oncology-240x160

This blog is the seventh of an eight-post ACCCBuzz series highlighting the achievements of the 2020 ACCC Innovator Award Winners. You can learn more about the innovations being recognized this year and the people who pioneered them by joining us at the upcoming ACCC 37th [Virtual] National Oncology Conference, Sept. 14-18.

The degree of success that participating cancer programs have had meeting the quality metrics established by the Oncology Care Model (OCM) depends in part on their ability to monitor and decrease their patients’ unanticipated hospital admissions and emergency department (ED) visits. Tennessee Oncology has participated in the OCM—a program of the Center for Medicare & Medicaid Innovation—since its inception in July 2016. Since then, the cancer center has achieved cost savings in all five of the program’s performance periods. Its quality multipliers for those periods have ranged from 75 percent to 100 percent.

A community cancer center based in Nashville, Tennessee Oncology is an independent practice that provides oncology/hematology services at more than 30 locations. The cancer center is also a founding practice partner of OneOncology—a partnership of oncologists and industry experts who work to advance community-based cancer care.

Larry Bilbrey, Tennessee Oncology’s care data systems manager, says achieving success in the OCM program has not been easy. When patients in treatment experience side effects and seek care at local emergency departments, their oncology providers may only find out afterward—if at all. Obtaining the patient treatment information that results from these trips to the ED has been historically difficult. “We chased that white whale for so long,” says Bilbrey. “How can we get this data and try to be proactive, or even reactive?”

“Unless the hospital calls me, or if the patient calls me to say they're in the hospital, we don't know,” adds Johnetta Blakely, MD, MS, MMHC, the executive director of health economics and outcome research at Tennessee Oncology. “Nobody wants to go to the ED or the hospital. Until you know when and why patients are going to the hospital, it's hard to put something in place that will prevent patients from ending up there.”

To address these issues, Tennessee Oncology has partnered with an IT vendor to customize and install a patient portal and database (known as a hospital event platform) that sends oncology providers real-time notifications when one of their patients presents at the ED, is admitted to the hospital, and/or is discharged from the hospital. The pandemic has postponed Tennessee Oncology’s contract with its vendor, causing the hospital to delay the implementation of the new event platform for now. Tennessee Oncology is taking the extra time to finalize workflows and determine the best location within the practice to implement the platform. “This is something that we really want to do,” says Dr. Blakely. “I think sometimes you just have to be able to be flexible.”

Because the main data depository being used to notify Tennessee Oncology about patient status was created by a vendor used by a previous state-wide project to track hospital admissions among Tennessee Medicaid patients, the platform the practice is implementing does not rely on electronic health record (EHR) systems. Thus, varying hospital EHRs will not affect Tennessee Oncology’s ability to receive real-time patient notifications.

Once notified, care coordinators will be able to log into the platform’s portal to view information about a patient event. The platform’s decision algorithms will help providers determine which action is needed. To help fast-track patient treatment, care coordinators can send the hospital or ED a patient’s most recent bloodwork, MRI, or other necessary information. The patient’s oncologist can contact the hospital or ED attending physician to help determine the best course of action.

For example, Dr. Blakely—also the chair of the performance improvement committee at Tennessee Oncology—may be notified by a care coordinator that a patient has presented in the ED, and she can contact the attending physician to discuss if hospital admission is necessary. If the patient is at the hospital in which Dr. Blakely is located, she may see the patient herself in her office. “Intervening in this way can help, so the patient doesn't actually require an ED visit,” says Dr. Blakely.

If patients do require the services of a hospital or ED, Tennessee Oncology follows up with patients within 48 hours of them being discharged. “If we have that information, we can have our care coordinators take action to follow up with patients, so they don't get readmitted,” says Bilbrey.

To bring this quality improvement project to fruition, Tennessee Oncology has created a transitional care team consisting of nurses, medical assistants, and medical records staff to coordinate patient care. An IT and implementation team provides tech support for the project.

Larry Bilbrey will deliver an in-depth presentation about the development of Tennessee Oncology’s hospital event platform at the ACCC 37th [Virtual] National Oncology Conference, September 14-18. Register for the session, “Utilizing Technology to Identify Patient Co-Morbidities and Reduce Hospital and ED Admissions.”

Attend the ACCC 37th [Virtual] National Oncology Conference to learn about the accomplishments of the other 2020 ACCC Innovator Award winners on topics ranging from the creation of a 3D educational tool that reduces patient distress, to onboarding experienced non-oncology nurses, to address staffing shortages.

Abstracts/Presentations